Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
KYTHERA Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of 'Double Chin'
Latest Articles from Benzinga.com
Posted on March 02, 2013 at 10:46 AM EST
KYTHERA Biopharmaceuticals (NASDAQ: KYTH ) today announced positive interim results from a Phase IIIb, multi-center, open-label study (ATX-101-11-26) to evaluate the safety and efficacy of ATX-101, an investigational
Read More >>
NewStar Financial, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here